Evaluation of serological anti-SARS-CoV-2 chemiluminescent immunoassays correlated to live virus neutralization test, for the detection of anti-RBD antibodies as a relevant alternative in COVID-19 large-scale neutralizing activity monitoring

The Spike-Receptor Binding Domain (S-RBD) is considered the most antigenic protein in SARS-CoV-2 and probably the key player in SARS-CoV-2 immune response. Quantitative immunoassays may help establish an anti-RBD Abs threshold as an indication of protective immunity. Since different immunoassays are...

Descripción completa

Detalles Bibliográficos
Autores principales: Cristiano, Antonio, Pieri, Massimo, Sarubbi, Serena, Pelagalli, Martina, Calugi, Graziella, Tomassetti, Flaminia, Bernardini, Sergio, Nuccetelli, Marzia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714258/
https://www.ncbi.nlm.nih.gov/pubmed/34971839
http://dx.doi.org/10.1016/j.clim.2021.108918

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714258/
https://www.ncbi.nlm.nih.gov/pubmed/34971839
http://dx.doi.org/10.1016/j.clim.2021.108918

Ejemplares similares